(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -168.31%-1.82M | -678.13K |
Payments to suppliers for goods and services | -168.31%-1.82M | ---678.13K |
Operating cash flow | -168.31%-1.82M | ---678.13K |
Investing cash flow | ||
Cash flow from continuing investing activities | 66.64%-371.21K | -1.11M |
Capital expenditure reported | 67.06%-364.47K | ---1.11M |
Net PPE purchase and sale | -9.23%-6.75K | ---6.18K |
Cash from discontinued investing activities | ||
Investing cash flow | 66.64%-371.21K | ---1.11M |
Financing cash flow | ||
Cash flow from continuing financing activities | 4.53M | |
Net issuance payments of debt | ---- | ---11.92K |
Net common stock issuance | ---- | --4.54M |
Cash from discontinued financing activities | ||
Financing cash flow | ---- | --4.53M |
Net cash flow | ||
Beginning cash position | 1,137.44%2.97M | --240.39K |
Current changes in cash | -180.12%-2.19M | --2.73M |
End cash Position | -73.64%784.03K | --2.97M |
Free cash from | -22.32%-2.19M | ---1.79M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data